View in EDS PDF Full Text

Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.

Saved in:
Bibliographic Details
Title: Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.
Authors: Grynblat J; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; M3C-Necker, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris Cité, Cardiologie Congénitale et Pédiatrique, Paris, France., Hlavaty A; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.; Grenoble Alpes University Hospital, Pharmacovigilance Unit and Clinical Pharmacology Department, Grenoble, France., Savale L; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Weatherald J; Department of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada., Le Bozec A; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France., Aguado B; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Chaumais MC; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France., Humbert M; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Khouri C; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France., Montani D; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
Source: ERJ open research [ERJ Open Res] 2025 Nov 24; Vol. 11 (6). Date of Electronic Publication: 2025 Nov 24 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41293777
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grynblat+J%22">Grynblat J</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; M3C-Necker, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris Cité, Cardiologie Congénitale et Pédiatrique, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hlavaty+A%22">Hlavaty A</searchLink>; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.; Grenoble Alpes University Hospital, Pharmacovigilance Unit and Clinical Pharmacology Department, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Savale+L%22">Savale L</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22Weatherald+J%22">Weatherald J</searchLink>; Department of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Le+Bozec+A%22">Le Bozec A</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France.<br /><searchLink fieldCode="AU" term="%22Aguado+B%22">Aguado B</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22Chaumais+MC%22">Chaumais MC</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France.<br /><searchLink fieldCode="AU" term="%22Humbert+M%22">Humbert M</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22Khouri+C%22">Khouri C</searchLink>; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Montani+D%22">Montani D</searchLink>; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101671641%22">ERJ open research</searchLink> [ERJ Open Res] 2025 Nov 24; Vol. 11 (6). <i>Date of Electronic Publication: </i>2025 Nov 24 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101671641 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2312-0541 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223120541%22">23120541 </searchLink><i>NLM ISO Abbreviation: </i>ERJ Open Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41293777
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/23120541.00382-2025
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grynblat J
      – PersonEntity:
          Name:
            NameFull: Hlavaty A
      – PersonEntity:
          Name:
            NameFull: Savale L
      – PersonEntity:
          Name:
            NameFull: Weatherald J
      – PersonEntity:
          Name:
            NameFull: Le Bozec A
      – PersonEntity:
          Name:
            NameFull: Aguado B
      – PersonEntity:
          Name:
            NameFull: Chaumais MC
      – PersonEntity:
          Name:
            NameFull: Humbert M
      – PersonEntity:
          Name:
            NameFull: Khouri C
      – PersonEntity:
          Name:
            NameFull: Montani D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 11
              Text: 2025 Nov 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2312-0541
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ERJ open research
              Type: main
ResultId 1